INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,000 | -23.0% | 72,683 | +3.4% | 0.00% | – |
| Q2 2023 | $639,000 | +63.4% | 70,308 | +16.1% | 0.00% | – |
| Q1 2023 | $391,000 | +1.8% | 60,539 | 0.0% | 0.00% | – |
| Q4 2022 | $384,000 | +2.4% | 60,539 | +0.0% | 0.00% | – |
| Q3 2022 | $375,000 | -27.9% | 60,528 | +2.8% | 0.00% | – |
| Q2 2022 | $520,000 | +19.8% | 58,867 | +14.1% | 0.00% | – |
| Q1 2022 | $434,000 | -3.3% | 51,606 | +17.2% | 0.00% | – |
| Q4 2021 | $449,000 | -81.7% | 44,031 | -65.2% | 0.00% | -100.0% |
| Q3 2021 | $2,455,000 | +110.2% | 126,411 | +90.2% | 0.00% | – |
| Q2 2021 | $1,168,000 | +49.9% | 66,458 | +1.4% | 0.00% | – |
| Q1 2021 | $779,000 | -20.6% | 65,548 | +15.0% | 0.00% | – |
| Q4 2020 | $981,000 | +98000.0% | 56,998 | +54705.8% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 104 | +3.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 101 | +12.2% | 0.00% | – |
| Q1 2020 | $0 | – | 90 | +200.0% | 0.00% | – |
| Q3 2019 | $0 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 178,284 | $1,219,463 | 0.13% |
| Fermata Advisors, LLC | 56,702 | $383,888 | 0.11% |
| Westside Investment Management, Inc. | 41,540 | $281,227 | 0.08% |
| QUADRANT CAPITAL GROUP LLC | 60,000 | $406,200 | 0.04% |
| MAI Capital Management | 97,410 | $659,466 | 0.01% |
| Janney Montgomery Scott LLC | 256,887 | $1,739 | 0.01% |
| Financial Advocates Investment Management | 11,510 | $78,320 | 0.01% |
| VALLEY NATIONAL ADVISERS INC | 1,000 | $7 | 0.00% |
| Beacon Pointe Advisors, LLC | 10,368 | $70,191 | 0.00% |
| Asset Dedication, LLC | 814 | $6 | 0.00% |